HC Wainwright maintains BridgeBio Pharma $120 price target
HC Wainwright & Co. maintained a $120.00/share price target for BridgeBio Pharma.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.